Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers

Monali Praharaj(Bloomberg (United States)), Jelani C. Zarif(Michigan State University)
Cancer Immunology Research
April 26, 2024
Cited by 44


Related Papers